Former CFO of GSK’s Global Vaccines Business Mr. Jay Green Joins BiondVax’s Board of Directors
JERUSALEM, Dec. 27, 2021 /PRNewswire/ -- BiondVax Prescription drugs Ltd. (Nasdaq: BVXV), a biopharmaceutical company centered on acquiring, manufacturing and commercializing progressive products for the...
